Zevenbergen Capital Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Sell
11,129
-35
-0.3% -$8.16K 0.06% 80
2026
Q1
$2.73M Buy
11,164
+200
+2% +$46.6K 0.08% 77
2025
Q4
$2.27M Buy
10,964
+185
+2% +$36.6K 0.05% 86
2025
Q3
$2M Buy
10,779
+40
+0.4% +$6.85K 0.04% 84
2025
Q2
$1.64M Buy
10,739
+350
+3% +$53.8K 0.03% 85
2025
Q1
$1.72M Sell
10,389
-335
-3% -$52.4K 0.04% 83
2024
Q4
$1.55M Sell
10,724
-3,500
-25% -$542K 0.03% 82
2024
Q3
$2.31M Buy
14,224
+345
+2% +$55K 0.05% 74
2024
Q2
$2.03M Sell
13,879
-1,015
-7% -$151K 0.04% 74
2024
Q1
$2.36M Buy
14,894
+500
+3% +$79.6K 0.05% 81
2023
Q4
$2.26M Buy
14,394
+120
+0.8% +$18.4K 0.05% 80
2023
Q3
$2.22M Buy
14,274
+175
+1% +$28.9K 0.06% 79
2023
Q2
$2.33M Sell
14,099
-175
-1% -$28.2K 0.06% 75
2023
Q1
$2.21M Buy
14,274
+100
+0.7% +$16.1K 0.06% 77
2022
Q4
$2.5M Buy
14,174
+610
+4% +$105K 0.08% 75
2022
Q3
$2.22M Buy
13,564
+290
+2% +$49.1K 0.06% 80
2022
Q2
$2.36M Sell
13,274
-25
-0.2% -$4.45K 0.11% 54
2022
Q1
$2.36M Buy
13,299
+855
+7% +$145K 0.06% 55
2021
Q4
$2.13M Buy
12,444
+1,910
+18% +$313K 0.04% 63
2021
Q3
$1.7M Buy
10,534
+110
+1% +$18.8K 0.03% 68
2021
Q2
$1.72M Buy
10,424
+340
+3% +$56.3K 0.03% 71
2021
Q1
$1.66M Buy
10,084
+1,310
+15% +$212K 0.03% 68
2020
Q4
$1.38M Buy
8,774
+300
+4% +$44.3K 0.02% 65
2020
Q3
$1.26M Hold
8,474
0.03% 59
2020
Q2
$1.19M Buy
8,474
+79
+0.9% +$11.5K 0.03% 59
2020
Q1
$1.1M Buy
8,395
+735
+10% +$104K 0.04% 54
2019
Q4
$1.12M Sell
7,660
-75
-1% -$10.2K 0.04% 58
2019
Q3
$1M Buy
7,735
+150
+2% +$19.8K 0.04% 58
2019
Q2
$1.06M Sell
7,585
-940
-11% -$130K 0.03% 57
2019
Q1
$1.19M Sell
8,525
-255
-3% -$34.2K 0.04% 51
2018
Q4
$1.13M Buy
8,780
+80
+0.9% +$11.2K 0.05% 50
2018
Q3
$1.2M Buy
8,700
+75
+0.9% +$9.97K 0.04% 56
2018
Q2
$1.05M Sell
8,625
-250
-3% -$31.2K 0.03% 60
2018
Q1
$1.14M Sell
8,875
-335
-4% -$45.3K 0.04% 55
2017
Q4
$1.29M Buy
9,210
+55
+0.6% +$7.66K 0.05% 50
2017
Q3
$1.19M Buy
9,155
+83
+0.9% +$11K 0.05% 53
2017
Q2
$1.2M Buy
9,072
+185
+2% +$23.6K 0.05% 51
2017
Q1
$1.11M Buy
8,887
+1,277
+17% +$153K 0.05% 53
2016
Q4
$877K Sell
7,610
-200
-3% -$23.1K 0.04% 56
2016
Q3
$923K Buy
7,810
+730
+10% +$88.6K 0.04% 56
2016
Q2
$859K Buy
7,080
+745
+12% +$84.7K 0.04% 51
2016
Q1
$685K Buy
6,335
+150
+2% +$15.5K 0.03% 50
2015
Q4
$635K Buy
6,185
+480
+8% +$48.3K 0.03% 52
2015
Q3
$533K Sell
5,705
-200
-3% -$19.3K 0.02% 51
2015
Q2
$576K Buy
5,905
+100
+2% +$10K 0.02% 51
2015
Q1
$584K Buy
5,805
+175
+3% +$17.8K 0.02% 52
2014
Q4
$589K Buy
5,630
+650
+13% +$68.5K 0.03% 60
2014
Q3
$531K Buy
4,980
+20
+0.4% +$2.07K 0.02% 52
2014
Q2
$519K Buy
4,960
+260
+6% +$26.3K 0.02% 54
2014
Q1
$462K Sell
4,700
-250
-5% -$23.2K 0.02% 59
2013
Q4
$453K Buy
4,950
+150
+3% +$13.8K 0.02% 58
2013
Q3
$416K Buy
4,800
+1,050
+28% +$94.2K 0.01% 53
2013
Q2
$322K Buy
+3,750
New +$318K 0.01% 51

Other funds holding JNJ

Zevenbergen Capital Investments's JNJ Position: Q2 2026 in Review

Zevenbergen Capital Investments reduced its Johnson & Johnson (JNJ) stake by 0.31% in Q2 2026, selling an estimated $8.16K and leaving 11,129 shares worth $2.83M. The position accounts for 0.06% of the portfolio, ranked #80.

Zevenbergen Capital Investments first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Zevenbergen Capital Investments held 11,129 shares of Johnson & Johnson worth $2.83M as of Q2 2026.
  • Zevenbergen Capital Investments sold 35 Johnson & Johnson shares in Q2 2026, an estimated $8.16K.
  • Johnson & Johnson made up 0.06% of Zevenbergen Capital Investments's portfolio in Q2 2026, its #80 holding.
  • Zevenbergen Capital Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Zevenbergen Capital Investments's 13F filing for Q2 2026, filed 16 Jul 2026.